INGR · the NYSE · USD · Market cap $6.3B · 11,000 employees
Ingredion Incorporated, together with its subsidiaries, engages in the manufacture and sale of sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and othe…
Screened 2026-09-11 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markdown label.
Ingredion Incorporated holds its Markdown at $100.49. Consolidating, no directional conviction, held for 140 days.
As held on the ledger · 2026-09-11
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 140 days
Price at the screen
$100.49
Valuation
10.92 trailing · 8.85 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.61
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
24.96%
Below 33%
Interest-bearing debt is just 25.0% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.04%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
26.10%
Below 49%
Money owed to the company is 26.1% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-11 screen. The gold marker is the market price at the same screen. A 43.7% margin of safety to the base estimate.
Third-party analyst targets: 6 covering, consensus None. The average target sits +15% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Corn Sweeteners Fuel Snacks But Growth Stalls
Walk past the cereal aisle or grab a soft drink and the odds are high that Ingredion supplied the starch or sweetener inside. The business turns corn into ingredients for packaged foods worldwide, earns a steady 16 percent return on equity and clears a 9 percent profit margin while passing every ethical test we apply. Revenue however slipped 1 percent and the market prices the shares at just 8.9 times forward earnings against our 145 dollar fair value, yet the opportunity rating stays at none.
Shifting diets toward fewer processed products and volatile crop prices both threaten volumes. A low single digit margin gives scant cushion if costs rise or customers switch suppliers, and six analysts already reflect that caution with a hold stance and 116 dollar median target.
The cheap multiple may simply mark the new normal for a business that has stopped expanding rather than signal a bargain.
Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
INGR trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-09-02Markup · changed$105.03+5.6%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (7 analysts) rates it buy, with a mean price target of $122.
2026-08-02Distribution$99.46-2.1%Entry 4
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (7 analysts) rates it buy, with a mean price target of $122.
2026-07-18Distribution$101.59+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 24%. Our forward projection puts the odds of a 10% gain over the next month near 8%. The street (7 analysts) rates it buy, with a mean price target of $122.
2026-07-03Distribution$101.59+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Distribution$101.59Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
